Glucocorticoid receptors: finding the middle ground
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Glucocorticoids (GCs; referred to clinically as corticosteroids) are steroid hormones with potent anti-inflammatory and immune modulatory profiles. Depending on the context, these hormones can also mediate pro-inflammatory activities, thereby serving as primers of the immune system. Their target receptor, the GC receptor (GR), is a multi-tasking transcription factor, changing its role and function depending on cellular and organismal needs. To get a clearer idea of how to improve the safety profile of GCs, recent studies have investigated the complex mechanisms underlying GR functions. One of the key findings includes both pro- and anti-inflammatory roles of GR, and a future challenge will be to understand how such paradoxical findings can be reconciled and how GR ultimately shifts the balance to a net anti-inflammatory profile. As such, there is consensus that GR deserves a second life as a drug target, with either refined classic GCs or a novel generation of nonsteroidal GR-targeting molecules, to meet the increasing clinical needs of today to treat inflammation and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068 · cited 1×
“In vivo evidence supporting a role for GR dimerization in mediating the anti-inflammatory effects of GCs was provided by studies of GRdim/dim mice (57), which express a GR that is compromised in its ability to form dimers.”
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
De Bosscher, K., Vanden Berghe, W., & Haegeman, G. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0006 · Cited by 898 · cited 2×
“For example, transrepression can involve a sequestration or squelching mechanism whereby the GR-targeted, DNA-bound TF detaches from the DNA, or a tethering mechanism whereby the GR remains associated with the DNA-bound TF (12).”
Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A., & Baldwin, A. S. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.943 · Cited by 819 · cited 1×
“These include the following nonexclusive (and sometimes debated) mechanisms by which GR mediates repression of NF-κB transcriptional activity: (a) GR-mediated tethering (26, 27) or squelching (28) of the NF-κB p65 subunit, (b) recruitment of histone deacetylase 2 by deacetylated GR to NF-κB–dependent promoters (a spec…”
Ramamoorthy, S., & Cidlowski, J. A. (2016) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.08.002 · Cited by 692
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638 · cited 1×
“These include the following nonexclusive (and sometimes debated) mechanisms by which GR mediates repression of NF-κB transcriptional activity: (a) GR-mediated tethering (26, 27) or squelching (28) of the NF-κB p65 subunit, (b) recruitment of histone deacetylase 2 by deacetylated GR to NF-κB–dependent promoters (a spec…”
Cited by
Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases
Hardy, R. S., Raza, K., & Cooper, M. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0371-y · Cited by 265
Somvanshi, P. R., Mellon, S. H., Yehuda, R., Flory, J. D., Makotkine, I., Bierer, L., Marmar, C., Jett, M., & Doyle, F. J. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00398.2019 · Cited by 55
Saitoh, B.-Y., Tanaka, E., Yamamoto, N., Kruining, D. V., Iinuma, K., Nakamuta, Y., Yamaguchi, H., Yamasaki, R., Matsumoto, K., & Kira, J.-I. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2021.04.008 · Cited by 47
Glucocorticoids mobilize macrophages by transcriptionally up-regulating the exopeptidase DPP4
Diaz-Jimenez, D., Petrillo, M. G., Busada, J. T., Hermoso, M. A., & Cidlowski, J. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010894 · Cited by 37
“These effects may depend on the type of inflammatory stimulus (10) and/or the timing of treatment (11), thus modulating the balance of the cellular state toward a net pro-inflammatory or anti-inflammatory state (7).”
BackgroundInteraction mechanisms between major depressive disorder and non-alcoholic fatty liver disease
Shao, Q., Wu, Y., Ji, J., Xu, T., Yu, Q., Ma, C., Liao, X., Cheng, F., & Wang, X. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.711835 · Cited by 32
“Body responses to GC depend on GC concentrations, physiological states of the body’s immune systems, and duration of stimulation (acute or chronic), among others (40).”
Background
Metadata
- Authors
- Desmet, S. J., & De Bosscher, K.
- Venue
- Journal of Clinical Investigation
- Published
- 2017-03-20
- Volume
- 127
- Issue
- 4
- Pages
- 1136-1145
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- OpenAlex
- W2596585859
- Cited by
- 147
- References
- 41
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucocorticoid receptors: finding the middle ground. https://app.cochat.ai/papers/10.1172/jci88886
- The paper
- Desmet, S. J., & De Bosscher, K. (2017). Glucocorticoid receptors: finding the middle ground. Journal of Clinical Investigation. https://doi.org/10.1172/jci88886
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.